1.24
Bionano Genomics Inc (BNGO) 最新ニュース
Bionano reports 56% jump in rare disease research publications By Investing.com - Investing.com Australia
Bionano reports 56% jump in rare disease research publications - Investing.com
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - The Manila Times
28 rare-disease studies back genome mapping for unresolved cases - Stock Titan
BNGO Should I Buy - Intellectia AI
Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - The Globe and Mail
Bionano Genomics stock rises on Q1 revenue beat - MSN
Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus - MSN
BNGO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 earnings call transcript - MSN
H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6 - Moomoo
BNGO Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Take Profit: Is Bionano Genomics Inc benefiting from interest rate changesWeekly Investment Report & Community Driven Trade Alerts - baoquankhu1.vn
Keys to Succeed in the Booming $300 Million Optical Genome - GlobeNewswire
Breakout Zone: What is Bionano Genomics Incs P E ratio telling us2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Aug Update: Is Bionano Genomics Inc part of any ETFQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Bionano Genomics stock price target lowered to $6 by H.C. Wainwright - Investing.com South Africa
Is Bionano (BNGO) Stock Stronger Than Peers | Price at $1.17, Up 1.74%Top Analyst Buy Signals - Cổng thông tin điện tử Tỉnh Sơn La
Weekly Recap: Is Bionano Genomics Inc stock a value trap2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO) - The Globe and Mail
Bionano Genomics earnings are imminent; these most accurate analysts revise forecasts ahead of earnings call - MSN
Bionano Genomics, Inc. (BNGO) stock price, news, quote and history - Yahoo Finance Singapore
BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BNGO Stock Analysis: Bionano Genomics Inc. holds 1.2 level with mild daily gain in genomics sector - Cổng thông tin điện tử tỉnh Tây Ninh
Bionano Genomics, Inc. (BNGO) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] Bionano Genomics, Inc. SEC Filing - Stock Titan
Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes - Stock Titan
Aug Highlights: Is Bionano Genomics Inc benefiting from interest rate changes2026 Buyback Activity & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - Bitget
In 211 myeloma samples, OGM found abnormalities older tests missed - Stock Titan
Q4 2024 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
BNGO Stock Analysis: Bionano Genomics Inc logs 1.71 pct gain to 1.19 in biotech - Cổng thông tin điện tử tỉnh Lào Cai
Volume Summary: Is Bionano Genomics Inc backed by strong institutional buying2026 PostEarnings & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Profit Review: Is Bionano Genomics Inc part of any ETFWeekly Trade Recap & High Accuracy Buy Signal Tips - baoquankhu1.vn
Bionano outlines $30M–$33M revenue target for 2026 with focus on routine user growth and margin expansion - MSN
Bionano Genomics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-03-24 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript - Insider Monkey
Bionano Genomics Reports 2025 Financial Results, Highlights OGM Adoption and Announces 2026 Revenue Outlook - minichart.com.sg
大文字化:
|
ボリューム (24 時間):